IMUNON, INC.

Profile

Company Names

IMUNON, INC.
CELSION CORP

Addresses

997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NJ 08648

10220 OLD COLUMBIA ROAD, SUITE L, COLUMBIA, MD 21046

Phone Numbers

(609) 896-9100
410-290-5390

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$35,539,745.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2025-05-27 
$3,250,001.00 
$3,250,001.00 
$0.00 
Equity 
5
2024-08-01 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
4
2015-06-01 
$5,070,000.00 
$5,070,000.00 
$0.00 
 
3
2014-06-20 
$8,500,000.00 
$8,500,000.00 
$0.00 
Equity 
2
2011-06-02 
$8,580,000.00 
$8,580,000.00 
$0.00 
Equity 
1
2010-06-17 
$139,744.00 
$15,139,744.00 
$15,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KHURSHEED 
 
ANWER 
EXECUTIVE OFFICER
EGEN, INC.   |  CELSION CORP   |  IMUNON, INC.
NICHOLAS 
 
BORYS 
EXECUTIVE OFFICER
CELSION CORP
DONALD 
 
BRAUN 
DIRECTOR
HALL STRUCTURED FINANCE, INC.   |  HALL ASSET HOLDINGS, LLC   |  HALL ARTS LAND DEVELOPMENT, LP   |  HALL STRUCTURED FINANCE SOMM HOTEL, LP   |  HALL STRUCTURED FINANCE PERRY HOTEL, LP   |  IMUNON, INC.   |  HS ORMOND BEACH, LLC
DONALD 
P. 
BRAUN 
DIRECTOR
IMUNON, INC.
AUGUSTINE 
 
CHOW 
DIRECTOR
CELSION CORP
JEFFREY 
W 
CHURCH 
EXECUTIVE OFFICER
CELSION CORP
JEFFREY 
W. 
CHURCH 
EXECUTIVE OFFICER
CELSION CORP
JAMES 
 
DENTZER 
DIRECTOR
VALERITAS INC   |  IMUNON, INC.
JAMES 
E. 
DENTZER 
DIRECTOR
IMUNON, INC.
SUSAN 
 
EYLWARD 
EXECUTIVE OFFICER
IMUNON, INC.
DOUGLAS 
 
FALLER 
EXECUTIVE OFFICER
IMUNON, INC.
FREDERICK 
 
FRITZ 
DIRECTOR
IMUNON, INC.
FREDERICK 
J. 
FRITZ 
DIRECTOR
CELSION CORP   |  IMUNON, INC.
DAVID 
 
GAIERO 
EXECUTIVE OFFICER
IMUNON, INC.
ROBERT 
W 
HOOPER 
DIRECTOR
CELSION CORP
ROBERT 
W. 
HOOPER 
DIRECTOR
CELSION CORP
STACY 
 
LINDBORG 
EXECUTIVE OFFICER, DIRECTOR
IMUNON, INC.
STACY 
R. 
LINDBORG 
EXECUTIVE OFFICER, DIRECTOR
IMUNON, INC.
MAX 
E. 
LINK 
DIRECTOR
CELSION CORP
ALBERTO 
 
MARTINEZ 
DIRECTOR
CELSION CORP
ALBERTO 
R 
MARTINEZ 
DIRECTOR
CELSION CORP
GARY 
W. 
PACE 
DIRECTOR
CELSION CORP   |  CARDIFF ONCOLOGY, INC.   |  TROVAGENE, INC.
CHRISTINE 
 
PELLIZZARI 
DIRECTOR
AEGERION PHARMACEUTICALS, INC.   |  TEMPEST THERAPEUTICS, INC.   |  IMUNON, INC.
ROBERT 
A 
REED 
EXECUTIVE OFFICER
CELSION CORP   |  OAKWORTH CAPITAL, INC.
MICHAEL 
 
TARDUGNO 
EXECUTIVE OFFICER
IMUNON, INC.
MICHAEL 
H. 
TARDUGNO 
EXECUTIVE OFFICER, DIRECTOR
CELSION CORP   |  IMUNON, INC.
TIMOTHY 
J. 
TUMMINELLO 
EXECUTIVE OFFICER
CELSION CORP
GREGORY 
 
WEAVER 
DIRECTOR
CELSION CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-05-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-05-27 
2024-08-16
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-08-01 
2015-06-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
 
2015-06-01 
2014-06-24
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2014-06-20 
2011-06-14
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2011-06-02 
2010-07-26
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2010-06-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
000000375
NONE
NONE
BROOKLINE CAPITAL MARKETS, A DIVISION OF ARCADIA SECURITIES, LLC
000044656
H.C. WAINWRIGHT + CO., LLC
000000375
H.C. WAINWRIGHT + CO., LLC
000000375
BROOKLINE CAPITAL MARKETS
000044656
BROOKLINE CAPITAL MARKETS
000044656
NONE
NONE
MAXIM GROUP LLC
120708
NONE
NONE
RODMAN + RENSHAW, LLC
NONE
FINANCIAL WEST GROUP
16668
REEDLAND CAPITAL PARTNERS
NONE